Relmada Therapeutics, Inc. (RLMD)
3.94
+0.20
(+5.35%)
USD |
NASDAQ |
Jan 20, 16:00
3.94
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Total Liabilities (Quarterly): 5.411M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 638.39M |
| Invivyd, Inc. | 46.09M |
| Arcellx, Inc. | 215.14M |
| Puma Biotechnology, Inc. | 87.59M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.88M |
| Shareholders Equity (Quarterly) | 9.466M |
| Current Ratio | 2.862 |